Loxoscelism is the syndrome caused by the brown spider Loxosceles gaucho bite in humans. Its effect on erythrocytes has been studied in humans, rabbits, pigs and guinea pigs. In this study, the damage that the L gaucho spider venom causes to the structure and function of erythrocytes in vivo was investigated in rabbits. Before and after the rabbits were envenomed, membrane proteins were studied through polyacrylamide gel electrophoresis and membrane function was ascertained using the osmotic fragility test, together with the highly sensitive technique of ektacytometry. Six New Zealand rabbits were inoculated by intradermal injection into the dorsal region (10 μg of venom/kg of body weight in 0.2 mL of saline). Blood was collected at 24, 48, 72 and 120 h after inoculation. The membrane protein study did not reveal any alteration in their relative band concentrations, but the osmotic fragility test showed increased hemolysis in slightly hypotonic sodium chloride solutions (at 0.6 and 0.55%). In addition, the ektacytometer study revealed greater deformability to increasing shear stress on the order of 3—30 Pascals when compared with controls, showing that the L gaucho venom does in fact alter red cell function.Human & Experimental Toxicology (2007) 26 , 817—821
Ministry of Health. Manual de diagnóstico e tratamento de acidentes peçonhentos. Brasília: Ministério da Saúde, Fundacao Nacional de Saude/Coordenacao de Controle de Zoonoses e Animais Peçonhentos, 1998.
2.
Futrell JM, Morgan BB, Morgan PNAn in vitro model for studying hemolysis associated with venom from the brown recluse spider (Loxosceles reclusa). Toxicon1979; 17: 355—62.
3.
Tavares FL, Souza-e-Silva Mcc, Santoro ML, Barbaro KC, Rebechi Imm, Sano-Martins ISChanges in hematological, hemostatic and biochemical parameters induced experimentallly in rabbits by Loxosceles gaucho spider venom. Hum Exp Toxicol2004; 23: 477—86.
4.
Bücherl W. Biology and venoms ofthe most important South American spiders of the genera Phoneutria, Loxosceles, Lycosa and Latrodectus. Am Zool1969; 9: 157—9.
5.
Barbaro KC, Cardoso JL, Eickstedt VR, Mota I. Dermonecrotic and lethal components of Loxosceles gaucho spider venom. Toxicon1992; 30: 331—8.
6.
Parpart AK, Lorenzi PB, Parpart ER, Gregg JR, Chase AMThe osmotic resistance (fragility) of human red cells. J Clin Invest1947; 26: 636—40.
7.
Mohandas N, Chasis JA. Red blood cell deformability, membrane material properties and shape: Regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol1993; 30: 171—92.
8.
Palek J.The red cell membrane. In Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Heamatology, McGraw-Hill Inc., 1995, 406—16.
9.
Barretto OCdeO, Satake M, Nonoyama K, Cardoso JLC. The calcium-dependent protease of Loxosceles gaucho venom acts preferentially upon red cell band 3 transmembrane protein. Braz J Med Biol Res2003; 36: 309—13.
10.
Tambourgi DV , Magnoli FC, von Eickstedt VR, Benedetti ZC, Petricevich VL, da Silva WD.Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol1995; 155: 4459—66
11.
Pangburn MK, Muller-Eberhard HJComplement c3 convertase: cell surface restriction of β1 h control and generation of restriction on neuraminidase-treated cells. Proc Nat Acad Sci of USA1978; 75: 2416—20.
12.
Fearon DTRegulation by membrane sialic acid of β1 h-dependent decay-dissociation of amplification c3 convertase of the alternative complement pathway. Proc Nat Acad Sci USA1978; 75: 1971—5.
13.
Wang RH, Phillips GR Jr, Medof ME et al. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest1993; 92: 1326—35.
14.
Kraus D., Medof ME, Mold C.Complementary recognition of alternative pathway activators by decay-accelerating factor and factor h. Infect Immunity1998; 66: 399—405.
15.
Tambourgi DV, De SouzaDa Silva MS, Billington SJ, Goncalves de Andrade RM, Magnoli FC, Songer JG, Van Den Berg CW. Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases . Immunity2002; 107: 93—101.
16.
Rauenbuehler PB, Cordes KA, Salhany IMIdentification of the hemoglobin binding sites on the inner surface of the erythrocyte membrane. Biochem Biophys Acta1982; 692: 361—70.
17.
Ligi F., Ciacci C, Palma F, Palma F. Comparative study of the cytoplasmic domain of band 3 from human and rabbit erythrocyte membranes. Comp Biochem Physiol B: Biochem Mol Biol1998; 121: 265—71.
18.
Wessels JM, Veerkamp JH. Some aspects of the osmotic lysis of erythrocytes.3. Comparison of the glycerol permeability and lipid composition of red blood cell membranes from eight mammalian species. Biochem Biophys Acta1973; 291: 190—6.
19.
Barretto OCdeO, Cardoso JL, De Cillo D. Viscerocutaneous form of loxoscelism and glucose-6-phosphate dehydrogenase deficiency. Rev Inst Med Trop São Paulo1985; 27: 264—67.
